Involvement of ubiquitination in the decrease of intestinal P-Glycoprotein in a streptozotocin-induced diabetic mouse model

Drug Metabolism and Pharmacokinetics

Volumn 27, Issue 5, 2012, Pages 548-552

  Nawa, Ayaka ^a   Fujita Hamabe, Wakako ^a   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Diabetes; Intestine; Nitric oxide; P glycoprotein; Ubiquitination

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN; NITRIC OXIDE DONOR; PROTEASOME; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ILEUM; INTESTINE; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; UBIQUITINATION; UPREGULATION;

EID: 84869122030     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-NT-152     Document Type: Article

References (22)

1. Liu, H., Liu, X., Jia, L., Liu, Y., Yang, H., Wang, G. and Xie, L.: Insulin therapy restores impaired function and expression of Pglycoprotein in blood-brain barrier of experimental diabetes. Biochem. Pharmacol., 75: 1649-1658 (2008).
2. Ogura, J., Fujikawa, A., Maruyama, H., Kobayashi, M., Itagaki, S. and Iseki, K.: Alteration of P-gp expression after intestinal ischemia-reperfusion following 16-h fasting in rats. Yakugaku Zasshi, 131: 453-462 (2011).
3. Nawa, A., Fujita-Hamabe, W. and Tokuyama, S.: Altered intestinal P-glycoprotein expression levels in a monosodium glutamate-induced obese mouse model. Life Sci., 89: 834-838 (2011).
4. Sugioka, N., Sato, K., Haraya, K., Maeda, Y., Yasuda, K., Fukushima, K., Ito, Y. and Takada, K.: Effect of streptozotocininduced diabetes mellitus on the pharmacokinetics of nelfinavir in rats. Biopharm. Drug Dispos., 29: 469-479 (2008).
5. Zong, J. and Pollack, G. M.: Morphine antinociception is enhanced in mdr1a gene-deficient mice. Pharm. Res., 17: 749-753 (2000).
6. Ikemura, K., Urano, K., Matsuda, H., Mizutani, H., Iwamoto, T. and Okuda, M.: Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells. J. Pharmacol. Exp. Ther., 328: 249-255 (2009).
7. Nawa, A., Fujita-Hamabe, W. and Tokuyama, S.: Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions. Life Sci., 86: 402-409 (2010).
8. Nawa, A., Fujita-Hamabe, W. and Tokuyama, S.: Regulatory action of nitric oxide synthase on ileal P-glycoprotein expression under streptozotocin-induced diabetic condition. Biol. Pharm. Bull., 34: 436-438 (2011).
9. Nawa, A., Fujita-Hamabe, W., Kishioka, S. and Tokuyama, S.: Decreased expression of intestinal P-glycoprotein increase the analgesic effects of oral morphine in a streptozotocin-induced diabetic mouse model. Drug Metab. Pharmacokinet., 26: 584-591 (2011).
10. Kameyama, N., Arisawa, S., Ueyama, J., Kagota, S., Shinozuka, K., Hattori, A., Tatsumi, Y., Hayashi, H., Takagi, K. and Wakusawa, S.: Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes. Biochim. Biophys. Acta, 1782: 355-360 (2008).
11. Geick, A., Eichelbaum, M. and Burk, O.: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem., 276: 14581-14587 (2001).
12. Castro, A., Bernis, C., Vigneron, S., Labbé, J. C. and Lorca, T.: The anaphase-promoting complex: a key factor in the regulation of cell cycle. Oncogene, 24: 314-325 (2005).
13. Powell, S. R.: The ubiquitin-proteasome system in cardiac physiology and pathology. Am. J. Physiol. Heart Circ. Physiol., 291: H1-H19 (2006).
14. Leng, S., Zhang, W., Zheng, Y., Liberman, Z., Rhodes, C. J., Eldar-Finkelman, H. and Sun, X. J.: Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1. J. Endocrinol., 206: 171-181 (2010).
15. Wing, S. S.: The UPS in diabetes and obesity. BMC Biochem., 9 (Suppl 1): S6 (2008).
16. Kageyama, M., Fukushima, K., Togawa, T., Fujimoto, K., Taki, M., Nishimura, A., Ito, Y., Sugioka, N., Shibata, N. and Takada, K.: Relationship between excretion clearance of rhodamine 123 and P-glycoprotein (Pgp) expression induced by representative Pgp inducers. Biol. Pharm. Bull., 29: 779-784 (2006).
17. Kwak, M. K., Huang, B., Chang, H., Kim, J. A. and Kensler, T. W.: Tissue specific increase of the catalytic subunits of the 26S proteasome by indirect antioxidant dithiolethione in mice: enhanced activity for degradation of abnormal protein. Life Sci., 80: 2411-2420 (2007).
18. Gao, Z., Zhang, J., Kheterpal, I., Kennedy, N., Davis, R. J. and Ye, J.: Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J. Biol. Chem., 286: 22227-22234 (2011).
19. Oustwani, C. S., Tsihlis, N. D., Vavra, A. K., Jiang, Q., Martinez, J. and Kibbe, M. R.: Nitric oxide increases lysine 48-linked ubiquitination following arterial injury. J. Surg. Res., 170: e169-e177 (2011).
20. Zhang, L. L., Lu, L., Jin, S., Jing, X. Y., Yao, D., Hu, N., Liu, L., Duan, R., Liu, X. D., Wang, G. J. and Xie, L.: Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats. Acta Pharmacol. Sin., 32: 956-966 (2011).
21. Yu, S., Yu, Y., Liu, L., Wang, X., Lu, S., Liang, Y., Liu, X., Xie, L. and Wang, G.: Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocininduced diabetic rats: is P-GP involved? Planta Med., 76: 876-881 (2010).
22. Banerjee, A., Kocarek, T. A. and Novak, R. F.: Identification of a ubiquitination-Target/Substrate-interaction domain of cytochrome P-450 (CYP) 2E1. Drug Metab. Dispos., 28: 118-124 (2000).